Related Experiment Video
Updated: Jun 25, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Multifunctional 3D-Printed Wound Dressings Containing a Combination of Synergistic Antimicrobials in the Management
Iman Mattar1,2,3, Guillermo Landa1,2,3, Marina Frutos-Lizano2,3
1Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.
Abstract:
Despite increased pre- and postoperative care and aseptic practices in surgical rooms, methicillin-resistant Staphylococcus aureus (MRSA) continues to colonize acute surgical wounds. MRSA is also present in chronic nonhealing wounds, such as diabetic foot and pressure ulcers. In this work, advanced antimicrobial-loaded wound dressings are 3D printed using fused deposition modeling. To achieve a high antimicrobial effect, the topical antiseptic octenidine (OCT) was incorporated into the pellets used in the feeder of the extruder prior to fused modeling. Lysostaphin (LYS), a lytic enzyme that cleaves MRSA peptidoglycan, was incorporated by supramolecular interactions on the surface of the OCT-loaded dressings to exploit the anti-MRSA synergy identified here between OCT and LYS showing a fractional inhibition concentration index (FICI) of 0.156. Minimum inhibitory concentration (MIC) and bactericidal concentration (MBC) values for the OCT were 1 and 25 μg/mL, respectively, whereas the MIC and MBC values for the LYS were 0.1 and 0.2 μg/mL, respectively. The resulting dressings completely eradicate MRSA USA 300 inocula (105 CFU/mL) in 96 h. The bactericidal mechanisms exerted by these dressings were identified through molecular techniques, showing lytic effects on the cell wall peptidoglycans of treated bacteria. Additionally, OCT at 1 μg/mL was able to reduce lipopolysaccharide (100 ng/mL)-induced NO production on murine J774A.1 macrophages by more than 90% demonstrating its simultaneous anti-inflammatory action. This effect was also corroborated by the qRT-PCR analysis of several pro-inflammatory genes including IL-1β, IL-6, TNF-α, and Nos2. The combination of OCT and LYS within the dressings reveals higher in vivo therapeutic effects compared to free compounds or individual antimicrobial-loaded dressings. In vitro and in preclinical models, the use of OCT-LYS dressings effectively reduces MRSA bioburden and inflammation, promoting fast wound healing.
Insights
Advanced 3D printed wound dressings combine octenidine (OCT) and lysostaphin (LYS) to effectively combat methicillin-resistant Staphylococcus aureus (MRSA) infections. These novel dressings demonstrate potent antimicrobial and anti-inflammatory properties, promoting faster wound healing.
Area of Science:
- Biomaterials Engineering
- Antimicrobial Therapeutics
- Wound Healing Research
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat to surgical wound healing.
- Existing wound care strategies struggle to effectively manage MRSA colonization in acute and chronic wounds.
- Novel antimicrobial delivery systems are needed to overcome MRSA resistance and promote healing.
Purpose of the Study:
- To develop advanced, 3D-printed wound dressings incorporating antimicrobial agents for MRSA eradication.
- To investigate the synergistic antimicrobial and anti-inflammatory effects of combining octenidine (OCT) and lysostaphin (LYS).
- To evaluate the efficacy of these novel dressings in preclinical wound models.
Main Methods:
- Fused deposition modeling was used to 3D print wound dressings loaded with OCT.
- Lysostaphin (LYS) was surface-functionalized onto OCT-loaded dressings via supramolecular interactions.
- Antimicrobial activity (MIC, MBC, eradication assays), synergistic effects (FICI), and anti-inflammatory properties (NO production, gene expression) were assessed.
- Preclinical models were used to evaluate in vivo therapeutic effects.
Main Results:
- The OCT-LYS combination exhibited significant synergy against MRSA (FICI = 0.156).
- The dressings completely eradicated MRSA USA 300 inocula (10^5 CFU/mL) within 96 hours.
- OCT demonstrated potent anti-inflammatory effects by reducing NO production and pro-inflammatory gene expression.
- OCT-LYS dressings showed superior in vivo therapeutic outcomes compared to individual components.
Conclusions:
- 3D-printed OCT-LYS wound dressings offer a promising dual-action approach against MRSA infections.
- These dressings effectively reduce bacterial burden and inflammation, facilitating accelerated wound healing.
- The synergistic combination of OCT and LYS represents a significant advancement in antimicrobial wound care.
More Related Videos
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
06:45Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance